Figure 8.
![(A) Fully synthetic vaccine target against N. meningitidis [21]. (B) Semisynthetic multipotent vaccine candidate against N. meningitidis and other bacteria [68].](https://port.silverchair-cdn.com/port/content_public/journal/biochemsoctrans/49/5/10.1042_bst20210766/1/bst-2021-0766c.08.png?Expires=1716940121&Signature=ExnspKYv8HDhI6WqfqSmEHrFzbzxiBaIaMKg7qMwnkge2lLwkuuKEOFCpSC74Cp7DHDuN-WGEOAA43mjs8EyANOTdyX2dsis0nxPqM7lJVT5Kbu2tROniU55SUWUitPWYymgJVqqLQVVIYB4Nic3xDfwk86F-UOWUk0sIwp210CxVWPHr6EVQLYJW5iN-WF-SQ2Gin0msKpGaR0bx1ChJPQshCY8NXhjvhZRgcLgDwmo-V4coAcfxXCqKIA~YYJo7lqL-96rbf2bNB5ghS~h5SJvhkcKh9SoQSLLMdSZBlTm50nU6K52P6hQ1YIvnydofrw4vn4tOImLP0ZkzWMKZA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
The structures of fully synthetic and multipotent vaccine candidates against Neisseria meningitidis.
(A) Fully synthetic vaccine target against N. meningitidis [21]. (B) Semisynthetic multipotent vaccine candidate against N. meningitidis and other bacteria [68].